Low dosage Hydrate Inhibitors Market: Environmental Regulations to Govern Demand Scenario: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028
- REP-GB-1298
- 2019-04-22
- Category: Chemicals & Materials
- 243 Pages
- Format:
Low Dosage Hydrate Inhibitors Market – Key Findings
-
The global low dosage hydrate inhibitors market size exceeded the revenues of US$ 51 Mn in 2018.
-
Low dosage hydrate inhibitors market value is projected to grow at a robust 8% CAGR over 2018–2028.
-
Increasing environmental concerns are pushing the use of low dosage hydrate inhibitors.
-
Europe accounted for a prominent share; however, Latin America is projected to grow at a higher growth rate.
-
Increasing offshore gas exploration and rising acceptance of low dosage hydrate inhibitors over thermodynamic hydrate inhibitors are important factors for the growth of the low dosage hydrate inhibitors market.
-
Demand for anti-agglomerate hydrate inhibitors is likely to see robust growth in terms of value during the forecast period.
-
Anti-agglomerate hydrate inhibitors are more biodegradable than kinetic hydrate inhibitors, which makes them the choice for environmental standard compliance.
Top 2 Factors Shaping the Low Dosage Hydrate Inhibitors Market
Growing Preference for Low Dosage Hydrate Inhibitors over Thermodynamic Inhibitors
Thermodynamic hydrate inhibitors have been in use to address challenges related to gas hydrates, particularly in the oil & gas industry. However, thermodynamic inhibitors, as are required in large volumes, account for significantly high logistical costs, and need substantially large storage tanks, followed by large injection lines.
Low dosage hydrate inhibitors on the other side are required in significantly less quantity and thus are cited beneficial for manufacturers in terms of costs, transportation, storage, and efficiency. Low dosage hydrates have been proven as cost-effective as well as effective hydrate treatment compounds, which will continue to foster their consumption over conventional thermodynamic hydrate inhibitors.
Increasing Compliance with Environmental Regulations
Increasing focus on environmental compliance in the oil & gas industry is pushing the demand for biodegradable materials. Usage of thermodynamic hydrate inhibitors is constrained by their low sustainable quotient, which has been pushing other environmentally sustainable alternatives – including low dosage hydrate inhibitors.
While manufacturers are constantly exploring new applications of low dosage hydrate inhibitors, they are also augmenting investments in product innovations to cater to sustainability demands.
Low Dosage Hydrate Inhibitors Market: Structure Analysis
-
Developmental strategy if key players in the global low dosage hydrate inhibitors market is concentrated at innovation in terms of high biodegradability and improved hydrate inhibition capabilities.
-
Strategic acquisitions are also being considered as a key to product portfolio expansion.
-
New product development with a combination of various other production chemicals is likely to emerge as a trending product differentiation strategy among prominent companies in the low dosage hydrate inhibitors market.
-
The global market for low dosage hydrate inhibitors is characterized by moderate-to-high competition, highlighting more profitable opportunities emerging in regions leading in offshore natural gas production.
Market Introduction
Hydrate inhibitors are used in order to prevent the formation of gas hydrates at lower temperature and high pressure conditions. There are two types of hydrate inhibitors – thermodynamic inhibitors and low dosage hydrate inhibitors. Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition. These are cost-effective chemicals and easy to use.
The primary advantages of low dosage hydrate inhibitors are that they require lower transportation costs, lower storage costs, and less maintenance; are effective during extended shut-ins; etc. Low dosage hydrate inhibitors are of two types – anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHIs). They are mainly utilized in onshore and offshore operations in the oil and gas industry.
The report on the global low dosage hydrate inhibitors market studied the market for the next ten years, i.e. 2018-2028. The report has market values in 000’ US$ and market volumes in tons, and we have considered 2017 as the base year for the low dosage hydrate inhibitors market.
The report on the global low dosage hydrate inhibitors market has numerous sections that describe the entire scope of study, segment-wise. Initially, in the first section of the report, we have provided the executive summary of the global low dosage hydrate inhibitors market. In that, we have offered the outlook of the global low dosage hydrate inhibitors market
In the second section of the global low dosage hydrate inhibitors market report, we offer the market overview, market definition, and market taxonomy. In the next section, the report has key trends and Porter’s analysis of the global low dosage hydrate inhibitors market.
Next section of the global low dosage hydrate inhibitors market report has the entire outlook of the market background. Under this, we have included GDP outlook by region, offshore rigs by region, oil and gas production outlook, natural gas demand, natural gas production outlook, global energy consumption overview, chemical industry outlook, and patent analysis of the low dosage hydrate inhibitors market.
In the next section of the global low dosage hydrate inhibitors market, value chain analysis has been included along with a list of the distributors and manufactures of low dosage hydrate inhibitors. The global low dosage hydrate inhibitors market report has forecast factors, drivers, restrains, trends, and opportunity analysis for low dosage hydrate inhibitor manufactures. The next section of the report includes the pricing analysis by region, global value (000’ US$) and global volume (tons) analysis for the historical as well as the forecasted years. In the following section of the report, the value and volume analysis by segment (by product type, by terrain type, and by country) has been described for all regions – North America, Latin America, Europe, South East, East Asia, Oceania, and the Middle East & Africa.
The next section of the report includes the emerging market analysis, and comparison analysis of emerging and global markets by value and volume. PEST analysis for emerging economies has been included under this section. In the final section of the global low dosage hydrate inhibitors market report, we have included the competition benchmark, market analysis by tier, market concentration, competition dashboard, and company profiles of low dosage hydrate inhibitors.
In the competition analysis section, the report highlights some of the top companies operating in the global low dosage hydrate inhibitors market, such as BASF SE, Schlumberger Limited, Arkema Group, Baker Hughes Incorporated (BGHE), Clariant AG, Ecolab Inc., Evonik Industries AG, Force Chem Technologies LLC, Halliburton Co., and Gas Hydrate LLC, among others.
Research Methodology
Market volume for low dosage hydrate inhibitors are inferred through in-depth secondary research and validated from primary resources or interviews We have collected the data from private as well as public sources, such as – annual reports, newsletter, magazines, research papers, Factiva, BVD (Bureau van Dijk), etc. The price for low dosage hydrate inhibitors is analyzed on the basis of product type – anti-agglomerate and kinetic hydrate inhibitors (KHI), which is inferred across the all seven regions. The global value of the low dosage hydrate inhibitors market is thus calculated from the data gathered from secondary as well as primary resources, utilizing average price and market volume
For the next 10 years forecast of the low dosage hydrate inhibitors market, various market viewpoints, macroeconomic factors, and challenging trends are observed. For forecasting the market, we have considered both, supply-side trends and demand-side trends, and other dynamics that have an impact on the low dosage hydrate inhibitors market.
Forecast has been conducted in term of CAGR, Y-O-Y growth, and absolute dollar opportunity, presenting the client with crystal clear insights and future opportunities as far as the low dosage hydrate inhibitors market is concerned.
Low Dosage Hydrate Inhibitors Market Reports - Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
3.3. Porter’s Analysis
4. Key Success Factors
4.1. Product Adoption Rate
4.2. Technology Adoption Rate
4.3. Strategic Promotional Strategies
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Offshore Rigs By Region
5.1.3. Global Oil & Gas Production Forecast Outlook
5.1.4. Natural Gas Demand Forecast
5.1.5. Natural Gas Production By Region
5.1.6. Global Energy Consumption
5.1.7. Shale Gas Resources By country
5.1.8. Global Chemical Sales
5.1.9. Parent Market Outlook
5.1.10. Patent Analysis
5.2. Value Chain Analysis
5.2.1. List of Distributors
5.3. Forecast Factors - Relevance & Impact
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. Global Low Dosage Hydrate Inhibitors Market Demand Analysis 2013-2017 and Forecast, 2018-2028
6.1. Historical Market Volume (Tons) Analysis, 2013-2017
6.2. Current and Future Market Volume (Tons) Projections, 2018-2028
6.3. Y-o-Y Growth Trend Analysis
6.4. Pricing Analysis
6.5. Global Low Dosage Hydrate Inhibitors Market Demand (000’US$ ) Analysis 2013-2017 and Forecast, 2018-2028
7. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (000’US$ ) and Volume Analysis By Product Type, 2013 - 2017
7.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Product Type, 2018 - 2028
7.3.1. Anti-Agglomerate (AA) inhibitors
7.3.2. Kinetic Hydrate Inhibitors (KHI)
7.4. Market Attractiveness Analysis By Product Type
8. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Terrain Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (000’US$ ) and Volume Analysis By Terrain Type, 2013 - 2017
8.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Terrain Type, 2018 - 2028
8.3.1. Onshore
8.3.2. Offshore
8.4. Market Attractiveness Analysis By Terrain Type
9. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Region
9.1. Introduction
9.2. Historical Market Size (000’US$ ) and Volume Analysis By Region, 2013 - 2017
9.3. Current Market Size (000’US$ ) and Volume Analysis and Forecast By Region, 2018 - 2028
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
10.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
10.4.1. By Country
10.4.1.1. U.S.
10.4.1.2. Canada
10.4.2. By Product Type
10.4.3. By Terrain Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Terrain Type
10.6. Market Trends
10.7. Key Market Participants - Intensity Mapping
10.8. Drivers and Restraints - Impact Analysis
11. Latin America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
11.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Rest of Latin America
11.4.2. By Product Type
11.4.3. By Terrain Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Terrain Type
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Europe Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
12.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. Italy
12.4.1.3. France
12.4.1.4. U.K.
12.4.1.5. Spain
12.4.1.6. BENELUX
12.4.1.7. Russia
12.4.1.8. Rest of Europe
12.4.2. By Product Type
12.4.3. By Terrain Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Terrain Type
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. South Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
13.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
13.4.1. By Country
13.4.1.1. India
13.4.1.2. Thailand
13.4.1.3. Indonesia
13.4.1.4. Malaysia
13.4.1.5. Rest of South Asia
13.4.2. By Product Type
13.4.3. By Terrain Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Terrain Type
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. East Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
14.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.2. By Product Type
14.4.3. By Terrain Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Terrain Type
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Oceania Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
15.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
15.4.1. By Country
15.4.1.1. Australia
15.4.1.2. New Zealand
15.4.2. By Product Type
15.4.3. By Terrain Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Terrain Type
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
16.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Northern Africa
16.4.1.4. South Africa
16.4.1.5. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Terrain Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Terrain Type
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Emerging Countries Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. Canada Low Dosage Hydrate Inhibitors Market Analysis
17.2.1. Introduction
17.2.2. Pricing Analysis
17.2.3. PEST Analysis
17.2.4. Market Value Proportion Analysis by Market Taxonomy
17.2.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.2.5.1. By Product Type
17.2.5.2. By Terrain Type
17.2.6. Canada Low Dosage Hydrate Inhibitors Market - Competition Landscape
17.2.7. Canada - Trade Analysis
17.3. The U.S. Low Dosage Hydrate Inhibitors Market Analysis
17.3.1. Introduction
17.3.2. Pricing Analysis
17.3.3. PEST Analysis
17.3.4. Market Value Proportion Analysis by Market Taxonomy
17.3.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.3.5.1. By Product Type
17.3.5.2. By Terrain Type
17.3.6. The U.S. Low Dosage Hydrate Inhibitors Market - Competition Landscap
17.4. Brazil Low Dosage Hydrate Inhibitors Market Analysis
17.4.1. Introduction
17.4.2. Pricing Analysis
17.4.3. PEST Analysis
17.4.4. Market Value Proportion Analysis by Market Taxonomy
17.4.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.4.5.1. By Product Type
17.4.5.2. By Terrain Type
17.4.6. Brazil Low Dosage Hydrate Inhibitors Market - Competition Landscape
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Low Dosage Hydrate Inhibitors)
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product foot print by Players
18.4.3. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Pricing Analysis by Competition
19.3. Competition Benchmarking
19.4. Competition Deep Dive
19.4.1. BASF SE
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
19.4.1.4. Sales Footprint
19.4.1.5. Strategy Overview
19.4.1.5.1. Marketing Strategy
19.4.1.5.2. Product Strategy
19.4.1.5.3. Channel Strategy
19.4.2. Schlumberger
19.4.3. Arkema Group
19.4.4. Ashland
19.4.5. ERO CHEM LLC
19.4.6. Halliburton
19.4.7. Baker Hughes Incorporated
19.4.8. Clariant Chemicals
19.4.9. Ecolab
19.4.10. GasHydrate LLC
20. Assumptions and Acronyms Used
21. Research Methodology
Low Dosage Hydrate Inhibitors Market Reports - List of Tables
Table 01: Global Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 02: Global Low Dosage Hydrate Inhibitors Market Value (000'US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 03: Global Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Region, 2013 – 2028
Table 04: North America Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 05: North America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 06: North America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 07: Latin America Low Dosage Hydrate Inhibitors Market Value (000'US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 08: Latin America Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 09: Latin America Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 10: Europe Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 11: Europe Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 12: Europe Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 13: South Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 14: South Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 15: South Asia Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 16: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 17: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 18: East Asia Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 19: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 20: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 21: Oceania Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 22: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Country, 2013 – 2028
Table 23: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 24: Middle East & Africa Low Dosage Hydrate Inhibitors Market Value (000’ US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 25: U.S. Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 26: U.S. Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 27: Canada Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 28: Canada Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Table 29: Brazil Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Product Type, 2013 – 2028
Table 30: Brazil Low Dosage Hydrate Inhibitors Market Value (000’US$) & Volume (Tons) Forecast by Terrain Type, 2013 – 2028
Low Dosage Hydrate Inhibitors Market Reports - List of Figures
Figure 01: Global GDP Growth Y-o-Y (%) Forecast Comparison by Region, 2016–2028
Figure 02: Global Oil & Gas Production Forecast Outlook
Figure 03: Demand Analysis of Natural Gas
Figure 04: Production of Natural Gas by Region (Bn Cubic Meters)
Figure 05: Global Energy Consumption by Fuel Type (2016)
Figure 06: Global Refined Product Demand by Region (2016)
Figure 07: Shale Gas Resources (Mn Cubic Meters)
Figure 08: World Energy Consumption by Energy Source (Quadrillion Btu)
Figure 09: 10 Prominent Countries of Chemical Sales (2016) by Value
Figure 10: Global Chemical Sales Share (2016) by Region
Figure 11: Global Low Dosage Hydrate Inhibitors Market Value (000'US$) , 2017-2028
Figure 12: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity Analysis, 2013–2028
Figure 13: Global Low Dosage Hydrate Inhibitors Market Value Analysis By Product Type (2018)
Figure 14: Global Low Dosage Hydrate Inhibitors Market Valve Analysis By Product Type (2028)
Figure 15: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 16: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 17: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 18: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Anti-Agglomerate Inhibitors Segment, 2017 – 2028
Figure 19: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Kinetic Hydrate Inhibitors Segment, 2017 – 2028
Figure 20: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2018)
Figure 21: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2028)
Figure 22: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 23: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 24: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 25: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Onshore Segment, 2017 – 2028
Figure 26: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Offshore Segment, 2017 – 2028
Figure 27: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2018)
Figure 28: Global Low Dosage Hydrate Inhibitors Market Analysis By Terrain Type (2028)
Figure 29: Global Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Region, 2018 & 2028
Figure 30: Global Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Region, 2017-2028
Figure 31: Global Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Region, 2017-2028
Figure 32: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by North America Segment, 2017 – 2028
Figure 33: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Latin America Segment, 2017 – 2028
Figure 34: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Europe Segment, 2017 – 2028
Figure 35: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Asia Segment, 2017 – 2028
Figure 35: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by East Asia Segment, 2017 – 2028
Figure 36: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Oceania Segment, 2017 – 2028
Figure 37: Global Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Middle East & Africa Segment, 2017 – 2028
Figure 38: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 39: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 40: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 41: North America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by US Segment, 2017 – 2028
Figure 42: North America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Canada Segment, 2017 – 2028
Figure 43: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 44: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 45: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 46: North America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 47: North America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 48: North America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 48: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 49: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 50: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 51: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Brazil Segment, 2017 – 2028
Figure 52: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Mexico Segment, 2017 – 2028
Figure 53: Latin America Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of LA Segment, 2017 – 2028
Figure 54: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 55: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 56: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 57: Latin America Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 58: Latin America Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 59: Latin America Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 60: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 61: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 62: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 63: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Germany Segment, 2017 – 2028
Figure 64: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Italy Segment, 2017 – 2028
Figure 65: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by France Segment, 2017 – 2028
Figure 66: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by U.K. Segment, 2017 – 2028
Figure 67: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Spain Segment, 2017 – 2028
Figure 68: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by BENELUX Segment, 2017 – 2028
Figure 69: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Russia Segment, 2017 – 2028
Figure 70: Europe Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of Europe Segment, 2017 – 2028
Figure 71: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 72: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 73: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 74: Europe Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 75: Europe Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 76: Europe Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 77: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 78: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 79: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 80: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by India Segment, 2017 – 2028
Figure 81: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Thailand Segment, 2017 – 2028
Figure 82: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Indonesia Segment, 2017 – 2028
Figure 83: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Malaysia Segment, 2017 – 2028
Figure 84: South Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of SA Segment, 2017 – 2028
Figure 85: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 86: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 87: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 88: South Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 89: South Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 90: South Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 91: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 92: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 93: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 94: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by China Segment, 2017 – 2028
Figure 95: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Japan Segment, 2017 – 2028
Figure 96: East Asia Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Korea Segment, 2017 – 2028
Figure 97: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 98: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 99: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 100: East Asia Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 101: East Asia Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 102: East Asia Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 103: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 104: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 105: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 106: Oceania Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Australia Segment, 2017 – 2028
Figure 107: Oceania Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by New Zealand Segment, 2017 – 2028
Figure 108: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 109: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 110: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 111: Oceania Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 112: Oceania Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 113: Oceania Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 114: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Country, 2018 & 2028
Figure 115: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Country, 2017-2028
Figure 116: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Country, 2017-2028
Figure 117: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by GCC Countries Segment, 2017 – 2028
Figure 118: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Turkey Segment, 2017 – 2028
Figure 119: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Northern Africa Segment, 2017 – 2028
Figure 120: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by South Africa Segment, 2017 – 2028
Figure 121: Middle East & Africa Low Dosage Hydrate Inhibitors Market Absolute $ Opportunity by Rest of MEA Segment, 2017 – 2028
Figure 122: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Type, 2018 & 2028
Figure 123: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Type, 2017-2028
Figure 124: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Type, 2017-2028
Figure 125: Middle East & Africa Low Dosage Hydrate Inhibitors Market Share and BPS Analysis By Terrain Type, 2018 & 2028
Figure 126: Middle East & Africa Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections by Terrain Type, 2017-2028
Figure 127: Middle East & Africa Low Dosage Hydrate Inhibitors Market Attractiveness Analysis Projections by Terrain Type, 2017-2028
Figure 128: Emerging Markets Low Dosage Hydrate Inhibitors Market Share by Country, 2018
Figure 129: Global Low Dosage Hydrate Inhibitors Market Share by Region, 2018
Figure 130: Global & Emerging Countries Low Dosage Hydrate Inhibitors Market Y-o-Y Growth Projections, 2017-2028
Figure 131: Global & Emerging Countries Low Dosage Hydrate Inhibitors Market Share and BPS Analysis – 2018 & 2028